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ABSTRACT 
Each year approximately ten million people deliberately harm themselves and one 
million people commit suicide across the world. Deliberate self-harm (DSH) is a major 
cause of individual suffering and a burden on the healthcare system. An attendance at 
an emergency department (ED) due to DSH increases the risk for subsequent suicide 
with 50 to 100 times compared to the general population. Repetition of DSH is very 
common (15−25%) and often occurs within a short period of time.  
The aim of this thesis was to gain a better knowledge of DSH patients in the somatic 
ED and to find ways of reducing the high repetition rate among this group of patients.  
The aims of the studies were to investigate risk factors associated with repeated DSH 
and suicide, to stratify a DSH population according to the risk of repetition, to develop 
and validate clinical decision rules that predict repetition of DSH and to investigate 
follow-up care for DSH patients and its impact on repeated DSH. 
Study I: In this study risk factors associated with repeated DSH among 1524 patients 
attending the ED due to DSH were identified and the patients were stratified into risk 
categories. New DSH or suicide was identified via national registers. A model for risk 
stratification for repeated DSH describing groups of low-risk (18%), median-risk (28% 
to 32%) and high-risk (47% to 72%) was presented. 
Study II: The aim was to develop a clinical decision rule, the Södersjukhuset Self-
harm Rule (SoS-4), based on factors found to be associated with repeated DSH in 
Study I and also to validate an existing clinical tool for assessing risk after DSH, i.e., 
the Manchester Self-Harm Rule (MSHR). The SoS-4 uses five clinical correlates: 
gender, antidepressant treatment, history of self-harm, admission to a psychiatric 
clinic and current psychiatric treatment. The MSHR uses four clinical correlates: 
history of self-harm, previous psychiatric treatment, self-poisoning with 
benzodiazepines and current psychiatric treatment. The SoS-4 yielded a sensitivity of 
90% and a specificity of 18% when applied to the DSH population in Study I and 
application of the MSHR yielded a sensitivity of 89% and a specificity of 21%. 
Study III: The aim was to prospectively validate the ability of the two clinical decision 
rules, SoS-4 and MSHR, to predict repetition of DSH in a new population and new 
setting. Included were 325 DSH patients in the EDs of Södersjukhuset and Karolinska 
University Hospital Huddinge who were followed for six months. Application of the 
SoS-4, to this new DSH population, yielded a sensitivity of 89% and a specificity of 
12% and application of the MSHR a sensitivity of 95% and a specificity of 18%. 
Study IV: The aim was to investigate follow-up care of DSH patients and its impact on 
repetition, which was done in the same study population as in Study III. A visit to a 
psychiatric consultant within 10 days was registered as an early follow-up. When 
adjusting for risk factors known to be associated with repetition there was an indication 
of early followed-up patients being less inclined to repeat their DSH actions. 
Conclusions: This thesis, focusing on DSH patients in a somatic ED, demonstrated that 
there are risk factors associated with repeated DSH that can be used to identify DSH 
patients at risk for repetition and that both clinical decision rules, the SoS-4 and the 
MSHR, can be useful in the clinical assessment of DSH patients in conjunction with 
psychiatric assessment. This thesis also demonstrated that there was an indication of 
early followed-up patients being less inclined to repeat their DSH actions after 
adjusting for risk factors known to be associated with repeated DSH. 
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INTRODUCTION 
DELIBERATE SELF-HARM AND SUICIDE 
The wish to live is essential to human beings. Deliberate self-harm is to be considered 
a disturbance of this essential wish and when people deliberately harm themselves it 
must be taken seriously and as an alert that an individual is not managing his or her 
situation or a certain period in his or her life.  
Each year about one million people die by suicide and the estimated number of 
people deliberately harming themselves is 10-20 times higher.
1
 Suicide and DSH are 
major public health problems in many parts of the world. The estimated annual 
suicide mortality rate is 14.5 deaths per 100.000 people, corresponding to one death 
every 40 seconds.
2
 DSH is the strongest clinical predictor of subsequent suicide 
where the risk of suicide increases 50 to 100 times within the year after an episode of 
DSH compared to the general population.
3 4
 
In somatic emergency departments (EDs) a large number of patients attending are 
patients who have deliberately harmed themselves and the frequency of repeated 
visits due to deliberate self-harm is high, up to 25%.
5
 ED visits due to DSH are 
increasing in many countries and these patients have persistent and elevated risks of 
suicidal behaviour and repeated ED visits.
6 7
 Repetition of DSH is frequent both 
immediately after a DSH episode and within the first year thereafter which results in 
individual suffering as well as a pronounced strain on EDs and health care services 
and could also be regarded as a failure to provide adequate care for these patients.
8-10
 
In the developed world, the majority of life-threatening and medically severe DSH 
patients are treated in somatic EDs but also the less medically severe DSH patients 
and those who present with suicidal ideation attend somatic EDs. The ED is an 
increasingly important site for DSH patients to come into contact with the healthcare 
system and thus provides an opportunity the to reach these patients and offer them 
adequate care and follow-up.
11
 DHS is far more frequent than suicide but the 
estimation of DSH is not an easy task as the registers of clinical services and hospital 
admission often are not entirely complete and there is, most importantly, a large 
number of DSH patients who do not present at clinical services. One way of 
illustrating the problem is by means of an iceberg model of DSH and suicide: 
Created by Uwe Kils. 
DSH patients presenting to hospital 
DSH patients not presenting to 
hospital 
Tip representing suicides 
 2 
Worldwide, suicide is one of the three leading causes of death among those in the 
most economically productive age group (15–44 years) and the second leading cause 
of death in the 15–19-year-old age group.12 The incidence of suicide varies between 
countries; in general, the highest rates are in Eastern Europe (Lithuania, the Russian 
Federation, Belarus and, to a lesser extent, Hungary and Latvia) and the lowest rates 
in countries that follow Islamic traditions.
2
 In all the Nordic countries, there is a trend 
towards declining suicide rates although Finland consistently presents the highest 
rates and also the highest male-to-female ratio (3:1), all Nordic countries present 
higher suicide rates among men than among women.
13
 
In Sweden about 1500 people die by suicide each year and 10 000 people are 
admitted to hospital due to DSH.
14
  The number of suicides in Sweden has been 
slowly decreasing during the last 30 years, whereas there has been an increasing 
number of young people admitted to hospital due to DSH, among both young men 
and young women although the trend seems to have levelled out over the past 2−3 
years.
15
  The numbers of hospital admissions due to DSH during the last ten years 
published by the Swedish National Board of Health and Welfare are presented below 
in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
DSH is the most important risk factor for subsequent suicide.
3 16
 Hawton et al 
conducted a follow-up study of 11583 DSH patients in England between 1979 and 
1997 and showed that the risk of subsequent suicide among  DSH patients was 66 
times higher than for the general population.
17
 Among individuals who die by suicide, 
20-25% have presented at a general hospital due to DSH in the year before 
committing suicide.
18
 The increased risk of suicide after DSH has been demonstrated 
by several other studies which confirm the strong association.
4 5 19 20
  
Figure 1 All hospital admissions due to DSH in Sweden/100.000 inhabitants 
 
Men 
 
Women 
Both genders 
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DSH is not only strongly associated with suicide, patients engaging in deliberate self-
harm also have an overall higher mortality than the general population. Physical 
health and life expectancy have been shown to be severely compromised in 
individuals who self-harm compared with the general population.
21 22
 
Runeson et al. showed that patients attempting suicide by use of a more violent 
method such as hanging, strangulation or suffocation had the highest risk of 
subsequent suicide. Within the group using more violent methods, 54% of the men 
and 57% of the women committed suicide during the follow-up period.
23
 Also the 
study by Bergen et al., including a large cohort of DSH patients, showed that 
individuals using a more dangerous method of DSH (hanging, carbon monoxide/other 
gases) were at higher risk of subsequent suicide.
24
 
The most frequently used method of DSH is self-poising with up to 80% of patients 
attending hospital due to DSH having used self-poisoning as method. The drugs used 
vary between different DSH populations but paracetamol, antidepressants and 
tranquilisers are among the most frequently used drugs.
25-27
 There is a wide variation 
in the methods used all over the world owing to different access to suicide means, in 
the USA for example the use of firearms is more common and in Southeast Asia the 
use of pesticides.
28 29
 
Definitions 
Despite suicide researchers’ attempts for half a century to find a uniform term for the 
entire range of suicidal behaviours there are still different terms used in different 
countries and by different research groups.  
Deliberate self-harm is the term used throughout this thesis to describe an intentional 
act of non-fatal, self-inflicted harms and includes all methods of self-harm. It denotes 
any act by an individual with the intention of harming him- or herself physically and 
which may result in some degree of harm. The patients’ motivations for DSH vary 
and are often difficult to investigate and the term DSH includes all DSH acts 
regardless of intention.
30-32
 Thus it includes DSH acts with high suicidal intent as well 
as acts where little or no suicidal intent is involved. An act of DSH is not necessarily 
even an indicator of suicide and it can sometimes be a form of self-preservation. 
Nevertheless, the term covers a wide spectrum of behaviour, with harmful physical 
effects. 
33 34
 
Other terms used in the literature are as presented in the review by Skegg
33
 ;  
 Attempted suicide:  used widely (especially in North America) for episodes 
where there was at least some suicidal intent.  
 Para-suicide: Any non‐fatal, serious, deliberate self‐harm with or without 
suicide intent.  
 Self-harm: same definition as deliberate self-harm. There is a trend towards 
the use of self-harm and not including the word deliberate. 
 Self-poisoning or self-injury: deliberate self-harm by these methods regardless 
of suicidal intent.
17
 
 Self-mutilation: serious bodily mutilation without suicidal intent, also known 
as self-injurious behaviour or self-wounding. 
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Methods of deliberate self-harm: 
Various different methods are used by patients who deliberately harm themselves, 
among which self-poisoning is the most common method used and is defined as the 
intentional self-administration of more than a prescribed dose of any drug or 
substance, whether or not there is evidence that the act was intended to result in 
death. Self-injury can result from very superficial cutting to injuries requiring a 
surgical procedure in an operating theatre and is defined as any injury which has been 
deliberately self-inflicted regardless of intention. Other methods of DSH include 
attempted hanging, jumping from heights, use of firearms, attempted gas poisoning 
and attempted suffocation. 
Gender paradox in suicide and deliberate self-harm  
Suicide 
A consistent finding in the research regarding DSH and suicide is that men commit 
suicide more often while there are more women who deliberately harm themselves 
which has been referred to as the gender paradox of suicidal behaviour.
35
 Reasons for 
this paradox have been discussed and explanations have been presented such as for 
example that men use more violent DSH methods than women and that there is a 
higher prevalence of substance use among men than among women, substance use 
being a risk factor for suicide.
36-38
 
The global suicide rate is nearly four times higher among men than among women. 
Although there are regional exceptions where higher ratios have been observed in the 
more developed, mostly European countries, and lower ratios in developing, mostly 
Asian countries and for example China has a higher suicide rate among women than 
among men.
2
 
39
  
Risk factors for suicide vary between men and women with, for example, 
unemployment, retirement and being single, having been shown to be risk factors for 
suicide in men. In women, being the parent of young children has been shown to be a 
protective factor for suicide. However adjusting for different risk factors do not 
eliminate the gender difference in suicide risk.
40
 A study by Isometsä et al. showed 
that more men than women die in their first suicide attempt (62% among the men and 
38% among the women) underlining the importance of early recognition of suicide 
risk especially among men.
41
 A recent DSH episode prior to suicide was more 
common among women in the same study. 
Deliberate self-harm 
There are considerable gender differences in suicidal behaviour overall with rates of 
DSH usually being higher in females although the gender differences vary between 
countries and regions, just as for suicide, with Asian countries having lower female-
to-male ratios of DSH than many of the European countries.
42
 DSH is most common 
among women aged 15–24 and fewer men than woman are admitted to hospital due 
to DSH. There has though been an increase in young men (aged 15-24) admitted to 
hospital due to DSH in Sweden and in the year  2011 more young men were admitted 
to hospital due to DSH than due to injuries caused by violence.
14
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The gender ratio for DSH presentations to hospital is often quoted as being 
approximately 1.5:1 (female:male). A study by Hawton and Harris confirmed this 
gender ratio but they also found important changes in the ratio across the life cycle. In 
patients of younger age the gender ratio was shown to be 1.5:1(female:male) as 
expected but from the age 50 years and onwards the pattern of the gender ratio was 
more similar to that for suicide, 0.8:1 (female:male).
43
  
The study by Hawton and Harris indicates that the gender paradox of suicidal 
behaviour is not a stable pattern but changes over the life cycle. The differences in 
gender ratios, both in suicide and DSH, between countries also indicate a dependence 
on the cultural environment.
39
  
RISK FACTORS FOR DELIBERATE SELF-HARM AND REPETITION 
The reasons for individuals engaging in DSH are multifactorial and there are different 
models for explaining their behaviour with a general consensus in suicide research 
and clinical psychiatry that stress-diathesis models are one appropriate way of 
attempting to explain the behaviour. The stress-diathesis models aims to explain how 
biological or genetic characters (diatheses) interact with environmental influences 
(stressors) to produce disorders. The stress-diathesis models emphasize that if the 
combination of the predisposition and the stress exceeds a threshold, the person in 
question will develop a disorder. The diathesis reflects a vulnerability to developing a 
disorder but requires other potentiating factors (stressors) to become pathogenic. The 
models include both predisposition and external stressors.
44
  
Figure 2 is an example of the stress-diathesis model of suicidal behaviour.  
 
 
Figure 2 
 
 
 
Adapted from Mann 2003. 
45
 
 
The stress component may include psychosocial crises and psychiatric disorders and 
these are not always separable (psychiatric disorders can lead to unemployment, 
social isolation or relationship problems and these psychosocial factors have all been 
associated with higher suicide risk).  
Suicidal behaviour 
Stressor 
Psychiatric disorder 
Psychosocial crisis 
Diathesis 
Hopelessness 
Impulsivity/Aggression 
 6 
The diathesis reflects a person’s vulnerability to develop a disorder and may be due to 
genetic and epigenetic effects and childhood difficulties and is reflected by a distinct 
biological, psychological or clinical profile. Both impulsivity or aggression and 
hopelessness have been shown to be more common in individuals engaging in 
suicidal behaviour even after controlling for psychiatric disorders.
46
 
 
The complex network of gene–environment interactions is demonstrated in this next 
model for suicidality adapted from Wasserman 2007 (Figure 3). 
47
 Relatively stable 
and constant parameters are boxed, whereas dynamic and acute parameters are 
encircled. Solid arrows show well-established interactions, whereas dotted arrows 
show hypothesized interactions. 
 
 Figure 3 
 
 
 
 
 
The boxes with black frames have been added as examples of gene expression 
(serotonin transporter gene), neurochemistry (serotonin levels), biochemistry (cortisol 
and noradrenaline levels), physical environment (substance abuse, head injury) and 
psychosocial factors (negative life events).  
As indicated in Figure 3 the reasons for suicidality are characterized by 
heterogeneous and complex causes. Environmental factors such as negative life 
events may often act as a significant contributor to suicidal behaviour. However, in 
many cases the exposure to the same environmental stress does not result in increased 
suicidality. Biological systems have been shown to be involved in suicidal behaviour: 
hyperactivity in the Hypothalamic-pituitary-adrenal axis (HPA-axis) influencing 
cortisol levels, increased activity in the noradrenergic system and dysfunction of the 
serotonergic system.  
Serotonin 
transporter gene 
Serotonin 
levels 
Cortisol, 
Noradrenaline 
Substance abuse, 
head injury 
Negative 
life events 
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The HPA axis and noradrenergic systems are involved in response to stress. The 
serotonergic system is involved in for example mood regulation. It is an established 
fact that there is also a substantial genetic and biological contribution to suicidal 
behaviour.
45 47
  
 
Factors associated with deliberate self-harm 
A risk factor increases the probability of an event to occur and an individual under the 
influence of a risk factor is more likely to experience the outcome than someone 
selected at random from the general population. 
There are many well known risk factors associated with DSH with psychiatric 
disorders such as mood disorders, substance use disorders and adult personality 
disorders being among the most consistently reported risk factors for DHS.
48
 
Demographic and socio-economic factors are also associated with DSH and the  main 
demographic risk factors for DSH include female gender, younger age, being single 
or divorced or having a lower educational level.
49
 
Risk factors found to be associated with DSH in different studies are listed in Table 1. 
Table 1 
Study Study population Risk factors for DSH 
Alaghehbandan et 
al. 200550 
978 DSH patients Female gender, single, younger 
age, low educational level 
Beautrais 200151 275 DSH patients  
(serious attempt) 
Psychiatric disorders, low 
income, low education, stressful 
life event 
Gratz et al. 200252 159 students, 18% reported 
DSH 
Insecure attachment, childhood 
separation, sexual abuse 
Haw et al. 200753 4391 DSH patients Relationship, employment, 
alcohol and financial problems 
Hawton et al. 200754 7344 DSH patients Female gender, younger age,  
Landstedt et al. 
201255 
1663 students,  
17.1% reported DSH 
Psychological distress, violence, 
school-related factors 
Lilley et al. 200810 7344 DSH patients Current or previous mental 
health contact 
Mahadevan et al. 
200856 
261 students presenting at  
hospital due to DSH 
Academic and relationship 
problems, eating disorders 
Nixon et al. 200857 96 youth reporting DSH Female gender, depressive 
mood, attention problems 
Perry et al. 201225 48.000 DSH patients Younger age, female gender 
Souminen et al. 
199648 
114 DSH patients Depression, alcohol abuse, 
comorbid mental disorders 
Welch 200158 Review of 20 studies Female gender, younger age, 
single, divorced, unemployed, 
mental disorder 
Yip et al. 201159 92 DSH patients Female gender, younger age, 
unemployed 
 8 
Factors associated with repeated deliberate self-harm 
A previous episode of DSH is the strongest predictor of repeated DSH (Table 2) but 
also other factors have been shown to be associated with repeated DSH. Listed in 
Table 2 below are risk factors found to be associated with repeated DSH in different 
studies. 
Table 2 
Study Population, follow-up, 
repetition rate 
Risk factors for repeated DSH 
Chung et al. 
201260 
39875 DSH patients, follow-up 
3 months-8years, 8% repeated 
Female gender,  psychiatric 
disorder 
Colman et al. 
200461 
369 DSH patients, follow-up 
1−2 years, 24.9% repeated 
Previous DSH, history of 
depression or schizophrenia, poor 
physical health 
Cooper et al. 
200662 
6933 DSH patients, follow-up 6 
months, 16.7% repeated 
Previous DSH, prior psychiatric 
treatment, benzodiazepine, 
current psychiatric contact 
Harris et al. 
200563 
2489 DSH patients, follow-up 1 
year, 15-18 % repeated 
Low suicide intent score among 
men 
Haukka et al. 
20088 
18199 DSH patients, follow-up 
8 years, risk of repetition 30% 
Mental disorder, alcohol abuse, 
female gender, 30−40 years of 
age 
Haw et al. 20075 4167 DSH patients, follow-up 6 
years, 24.5% repeated 
Previous DSH, personality 
disorder 
Howson et al. 
200864 
754 DSH patients, follow-up 1 
year, 18% repeated 
Female gender 
Kapur et al. 
200665 
9213 DSH patients, follow-up 
12 months, 13.6% repeated 
Previous DSH, psychiatric 
treatment, unemployed, alcohol 
abuse, self-injury, suicidal plans 
Kapur et al.200466 658 DSH patients, follow-up 6 
months, 14.6% repeated 
Previous DSH, psychiatric contact, 
male, young age, alcohol/drug 
abuse 
Oh et al. 201167 967 DSH patients, follow-up 9 
years, 21% repeated 
Female gender, living alone, 
history of psychiatric treatment, 
antidepressant treatment 
Owens et al. 
199468 
992 DSH patients, follow-up 1 
year, 12% repeated 
Previous DSH, prior psychiatric 
treatment, unemployment, more 
than 1 drug used 
Sinclair et al. 
201069 
101 DSH patients, follow-up 6 
years, 57.4% repeated 
Alcohol abuse, unemployment, 
divorce 
Yip et al. 201159 90 DSH patients, follow-up 6 
months, 16.7% repeated 
Previous DSH, single, subject to 
violence, personal problems, 
childhood abuse 
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Some of the studies include both psychiatric and sociodemographic factors to 
evaluate risk of repetition which is of importance due to the multifactorial reasons for 
DSH acts.  
Two of the studies (Colman et al., Haukka et al.) include specific psychiatric 
diagnosis when evaluating the risk of repetition while the other studies use the more 
unspecific factor psychiatric disorder to evaluate risk of repetition. Only one of the 
studies has used the factors found to be associated with repetition to classify patients 
according to risk of repetition (Cooper et al.). None of these studies were conducted 
in a Swedish population. 
Clinical decision rules 
A clinical decision rule is defined as a decision making tool derived from original 
research and has been developed to help physicians with diagnostic and therapeutic 
decision when handling different conditions. The development of clinical decision 
rules includes investigating the need for a rule, continuation according to 
methodological standards, prospective validation and refinement, implementation in 
clinical practise and  the rules’ cost-effectiveness.70 
There are different clinical tools for assessing suicide intent such as for example 
Beck`s Suicide Intent Scale which studies have shown to be a valuable tool in clinical 
suicide risk assessment.
71 72
 Also a scale developed by Jokinen et al., the Karolinska 
Interpersonal Violence Scale correctly identified suicide attempters who subsequently 
committed suicide.
73
 It is however difficult to predict subsequent suicide after DSH, 
in part due to the rarity of the event, even though several studies have demonstrated 
predictive values of DSH patients characteristics which indicate a higher risk of 
subsequent suicide.
74 75
 
Owing to the high repetition frequency of DSH there is an indication for clinical 
decision rules to help identify patients at higher risk of repetition in order to be able to 
allocate the right resources for these patients.
76 77
  
Only a few studies have used risk factors found to be associated with repeated DSH 
to develop clinical tools to facilitate assessment in the ED. Cooper et al. in the UK 
have developed a clinical decision rule for assessing risk after self-harm, the 
Manchester Self-Harm Rule (MSHR), for use by ED clinical staff to identify patients 
at a high risk of repeating DSH within 6 months.
62
 The MSHR uses four clinical 
correlates to identify DSH patients at higher risk of repetition and focuses on high 
sensitivity as often must be the case in emergency medicine settings. Also a modified 
version of this clinical decision rule, the ReACT Self-Harm Rule has been developed 
in the UK to identify patients at higher risk of repeated DSH and was derived from a 
multicenter study including both DSH patients receiving psychosocial assessments 
and those not receiving psychosocial assessments.
77
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PREVENTING DELIBERATE SELF-HARM 
One model for suicidal behaviour prevention is to divide preventive measures into 
universal, selected and indicated prevention. Universal preventions are directed at a 
population base, selective preventions are directed at individuals at greater risk for 
suicidal behaviour and indicated preventions are aimed at individuals who have 
already deliberately harmed themselves.
78
 In preventing DSH, various approaches are 
needed owing to the complexity of suicidal behaviour.
79 80
 
There are universal preventive measures that have been shown to be effective:  
 Withdrawal of the method by deregistration of, for example, co-proxamol 
(paracetamol and dextropropoxyphene).
81
 
 Reducing the availability of the method by, for example, restricting the 
amount of paracetamol and salicylate tablets sold in non-pharmacy outlets.
82
 
 Reducing ease of access to the method by, for example, building safety 
barriers on bridges and removal of potential rope points on in-patient wards.
83
 
 Training of general practitioners to recognize and treat mental disorders.80 
There are selective preventive measures that have been shown to be effective:  
 Antidepressant treatment to decrease the risk of suicidal behaviour among 
depressed patients.
84
 
 Lithium treatment to decrease the risk of suicidal behaviour among patients 
with bipolar disorders.
85
 
 Clozapine treatment to decrease the risk of suicidal behaviour among patients 
with schizophrenia.
86
 
Indicated prevention  
Only a minority of patients attending hospital due to DSH receive adequate care, 
although facilitation of follow-up care after DSH has been suggested as a promising 
strategy for preventing repeated DSH and suicide.
80
 
The results are, however, inconsistent regarding follow-up care after DSH and its 
influence on reduced repeated DSH rates or subsequent suicide:  
 A systematic review by Crawford et al. of psychosocial interventions 
following DSH did not provide evidence for any effect on subsequent 
suicide.
87
  
 A randomized controlled trial of assertive outreach by Morthorst et al. after 
DSH could not show a significant positive effect on the rate of repeated DSH 
either. 
88
  
 A review by Daigle et al. of treatments to prevent repetition of DSH showed 
positive effects with reduced repetition rates of DSH among patients receiving 
cognitive behavioural therapy (CBT) and psychoanalytically oriented 
treatments in 8 out of 16 studies and there were also, in a few studies, positive 
effects of phone contact or outreach programmes on repeated DSH.
89
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 Hawton et al. reviewed the efficacy of psychosocial and pharmacological 
treatments in preventing repetition of DSH and found significantly reduced 
rates of repeated DSH for flupenthixol versus placebo and for dialectical 
behaviour therapy (DBT), although they requested further large trials of 
treatment.
90
 
 A randomized controlled trial of brief psychological intervention after DSH 
(self-poisoning used as the method) showed a significant reduction in suicidal 
ideation and self-reported DSH in the intervention group.
91
 Also other studies 
on social and psychological treatments have demonstrated a positive impact 
on DSH repetition rates.
92 93
 
 Behavioural therapies, CBT and DBT have been shown to be effective in 
reducing repetition rate of DSH.
94 95
 The randomized controlled trial by Slee 
et al., in which a short CBT intervention supplemented the usual care was 
compared with only the usual care, showed that additional CBT was effective 
as a tool to reduce repetition of DSH.
96
 
Indicated preventive measures, even low-intensive ones, may be effective for 
reducing the risk of repeated DSH, but there is still a need for a stronger evidence 
base regarding indicated prevention of suicidal behaviour.
97
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AIMS OF THE THESIS 
 
This thesis focused on DSH patients in a somatic emergency department and aimed at 
gaining better knowledge of DSH patients and finding ways of reducing the high 
repetition rate among this group of patients.  
 
 
The specific aims of the studies were to: 
 
 Investigate risk factors associated with repeated DSH among patients 
attending the emergency department due to DSH, stratify these patients into 
risk categories for repeated DSH, and estimate the proportion of repeated 
DSH. 
 
 Develop a novel clinical decision rule based on factors associated with 
repeated DSH in a Swedish population, the Södersjukhuset Self-Harm Rule, 
and validate an existing clinical decision rule for assessing risk after DSH, 
the Manchester Self-Harm Rule. 
 
 Prospectively validate the ability of the clinical decision rules, the 
Södersjukhuset Self-Harm Rule and the Manchester Self-Harm Rule, to 
predict repetition of DSH. 
 
 Investigate whether an early follow-up of DSH patients could reduce the 
high frequency of repeated DSH. 
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MATERIAL AND METHODS 
NATIONAL REGISTERS 
In the studies information from the National Inpatient Register, the National 
Outpatient Register and the Causes of Death register maintained by the National 
Board of Health and Welfare in Sweden was used. Information regarding 
sociodemographic factors from Statistics Sweden, specifically from the Register of 
the Total Population (RTB) and labour statistics (RAMS) was also used in the 
studies. 
Swedish Population Register 
All residents of Sweden are included in the Swedish Population Register under a 
unique personal identification number allocated at birth or on receiving a residence 
permit. Each visit to an ED, admission to hospital or out-patient contact is recorded 
with the patient’s personal identification number, thereby enabling automatic and 
accurate record linkages. The registers of Statistics Sweden and the National Board of 
Health and Welfare are linked by personal identification numbers. 
National Board of Health and Welfare 
The National Board of Health and Welfare in Sweden is a government agency under 
the Ministry of Health and Social Affairs, with many different duties within the fields 
of social services, health and medical services, environmental health, communicable 
disease prevention and epidemiology. The National Board of Health and Welfare 
undertake official duties such as maintaining health data registers and official 
statistics. The National Inpatient Register, covering all somatic and psychiatric 
hospital discharges with diagnoses coded according to the International Classification 
of Diseases (ICD), and also the National Outpatient Register are maintained by the 
National Board of Health and Welfare. The National Inpatient Register has an almost 
100% coverage and has high validity for many (although not all) diagnoses.
98
 The 
National Board of Health and Welfare also maintain the Causes of Death Register. 
Statistics Sweden 
Statistics Sweden is an administrative agency with the task of supplying customers 
with statistics for decision making, debate and research. Statistics Sweden is mainly 
assigned these tasks by the government and different agencies, but also by customers 
in the private sector and researchers. Besides producing and communicating statistical 
data, Statistics Sweden support and coordinate the Swedish system for official 
statistics and participate in international statistical collaborations. The Register of the 
Total Population is an extraction from the Swedish Population Register which is 
maintained by the Swedish Tax Agency and is mainly used as a base register to 
produce statistics regarding population size and composition and for statistics 
regarding for example migrations, births, deaths, marriages and divorces. Labour 
statistics from administrative sources (RAMS) offer annual information on 
employment, commuters, employees and industrial structures and also illustrate 
occurrences and flows on the labour market.  
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International Classification of Diseases 
The International Classification of Diseases (ICD) is the standard diagnostic tool for 
epidemiology, health management and clinical purposes. It is used to monitor the 
incidence and prevalence of diseases and other health problems. In addition to 
enabling the storage and retrieval of diagnostic information for clinical, 
epidemiological and quality purposes, these records also provide the basis for the 
compilation of national mortality and morbidity statistics by WHO member states. 
The International Classification of Diseases 10 (ICD-10) is used by both somatic and 
psychiatric care units and the ICD-10 codes X60-X84 describe intentional self-harm 
and intentional self-poisoning. 
STUDY SETTINGS  
Södersjukhuset (Stockholm South General Hospital) is situated in the city central part 
of the capital of Sweden and is one of Scandinavia’s largest EDs with over 110.000 
visits per year and the hospital serves over 600.000 people in the region. Karolinska 
University Hospital Huddinge is situated further out from the city and has about 
80.000 ED visits per year and has a base catchment area of about 250 000 people. 
Both hospitals are university level hospitals. At Södersjukhuset there is a psychiatric 
emergency consult team available at all hours but the hospital has no psychiatric 
inpatient wards. At Karolinska University Hospital Huddinge there is a psychiatric 
emergency department open all hours and there are also psychiatric inpatient wards. 
STUDIES I AND II 
Studies I and II were based on ED register complemented with a review of somatic 
and psychiatric hospital records and national registers, with a nationwide follow-up 
via the Swedish National Board of Health and Welfare registers. All patients over 18 
years of age treated at the ED of Södersjukhuset due to DSH during the time period 
from 1 January 2003 to 31 December 2005 were included. The index episode 
(inclusion of the patient) was defined as the first DSH attendance that led to a 
psychiatric assessment (registered by the psychiatric consultant) during the period 
(2003–2005) or, if a psychiatric assessment was not made, the first DSH attendance 
of an individual during the study period. Patients were included by searching the 
register of the psychiatric emergency consult team and by searching the ED register 
which includes the patient’s main reason for attending the ED ensuring inclusion of 
all DSH patients if the main reason for attending the ED was DSH. 
Baseline data 
A structured protocol to collect data regarding explanatory factors from the hospital 
charts (medical and psychiatric history and examination) was used. The protocol 
included method of DSH, if the self-injury required a surgical procedure i.e. general 
anaesthesia or admission for surgery, the substance used for self-poisoning, current 
and previous psychiatric treatment, current antidepressant treatment, influence of 
alcohol at the time of self-harm (serum ethanol, ‰ or whether it was clearly 
mentioned in hospital charts that the patient was under the influence of alcohol), 
precipitant events before the DSH episode, suicidal intention, discharge information 
and psychiatric diagnosis listed by group by the psychiatric consultant at 
Södersjukhuset.  
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Additional data regarding explanatory factors were also collected from Statistics 
Sweden including sociodemographic factors such as age, gender, marital status, 
housing status, employment, educational level and early retirement pension. 
The explanatory factors collected were based on a substantive literature review of 
DSH and specifically on factors associated with repeated DSH. 
In Study II the variables, among the explanatory factors, that could be used in an ED 
setting by clinical staff without psychiatric expertise were selected in order to develop 
a useful clinical tool for any ED with or without psychiatric consultants. This meant 
that in Study II the psychiatric diagnosis listed by group by the psychiatric consultant 
were not included.  
Data on episodes of DSH before index registered at any healthcare unit in Sweden 
were collected from the Swedish National Board of Health and Welfare records. The 
use of the ICD-10 by both somatic and psychiatric care units made it possible to 
identify episodes of DSH before index (2002–2005) from the National Inpatient 
Register and the National Outpatient Register.  
Follow-up 
Data on repeated DSH or death by suicide (2003–2006) were collected from the 
registers of the Swedish National Board of Health and Welfare, providing a 
nationwide follow-up. Use of the ICD-10 codes X60-X84 made it possible to identify 
repeated DSH and suicide from the National Inpatient Register, the National 
Outpatient Register and the Causes of Death Register. 
STUDIES III AND IV 
In Studies III and IV all patients over the age of 18 years attending the ED of 
Södersjukhuset and the ED of Karolinska University Hospital Huddinge due to DSH 
during the time period of 22 March 2011 to 30 June 2011 were included. Each 
patient´s first attendance to the EDs due to DSH during the study period was defined 
as the index episode. A clinical decision rule sheet was attached to the clinical record 
by the triage nurse. The clinical decision rule sheet was also available in all sections 
of the ED and it was filled in by the physician treating the patient in the ED.  
Baseline data 
It was recorded whether or not the patients were seen at a follow-up visit to a 
consultant at any psychiatric care unit within ten days by searching data hospital 
records. In Stockholm, Sweden the majority of the hospitals and open care units use 
computerized hospital records that are connected which made it possible to identify 
follow-up visits not only at the hospital where the patient was treated at the index 
episode but with-in health care units of the Stockholm region. 
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To be clear about any differences between the patients attending Södersjukhuset and 
Karolinska University Hospital Huddinge and between early followed-up and not 
early followed-up patients, additional information regarding sociodemographic 
factors, admission to somatic care, and admission to psychiatric care, psychiatric 
diagnosis and severity of the deliberate self-harm act from hospital charts (medical 
and psychiatric history and examination) was collected by using a structured study 
protocol.  
Severity of the DSH act was classified as low if the patient had taken less than 10 
tablets or had a very superficial self-injury, as moderate if more than 10 tablets but 
less than 100 tablets had been taken or if the self-injury was handled only in the ED 
and as high if more than 100 tablets or a lethal drug had been taken or if the self-
injury required an operation in an operating theatre. For example, warfarin and insulin 
was defined as lethal drugs.  
Data on episodes of DSH before index registered at any healthcare unit in Sweden 
were collected from the Swedish National Board of Health and Welfare records. The 
use of the ICD-10 by both somatic and psychiatric care units made it possible to 
identify episodes of DSH before index from the National Inpatient Register and the 
National Outpatient Register.  
Clinical decision rules 
The clinical decision rule Södersjukhuset Self-Harm Rule (SoS-4) was developed in 
Study II using multivariable logistic regression to predict repetition of DSH. The 
SoS-4 uses five clinical correlates: gender, antidepressant treatment, history of DSH, 
admission to a psychiatric clinic and current psychiatric treatment. Based on this 
model, the estimated risk for a patient to repeat DSH within six months can be 
calculated and categorized to a moderate/high risk group or to a low risk group. 
The Manchester Self-harm Rule (MSHR) was validated in Study II and uses four 
clinical correlates: history of self-harm, previous psychiatric treatment, self-poisoning 
with benzodiazepines, and current psychiatric treatment. Patients who have any of the 
above clinical correlates are classified as belonging to a moderate/high risk group and 
only the patients without any of the four clinical correlates are classified as belonging 
to a low risk group regarding the risk of repeated DSH within six months. 
The clinical decision rule sheet, filled in by the physician treating the DSH patient in 
the ED, included the factors used in the SoS-4 and the MSHR.  
Follow-up 
Data on repeated DSH within six months after the index episode were collected from 
the registers of the Swedish National Board of Health and Welfare, providing a 
nationwide follow-up. Use of the ICD-10 codes X60-X84 made it possible to identify 
repeated DSH from the National Inpatient Register and the National Outpatient 
Register. 
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STATISTICAL METHODS 
Cox proportional hazard models 
Cox proportional hazard models were used to evaluate the influence of different 
factors on the risk of repetition and to account for differences in the length of follow-
up. Risk time (person-days) was accumulated from the index episode of DSH up to 
the first repetition or suicide or censoring for death from other causes or at the end of 
follow-up, whichever occurred first. The unadjusted association between repetition 
and each separate factor was studied in univariable models. The adjusted association 
was studied in multivariable models developed by including factors that showed an 
association (p value <0.05) with repetition. Hazard ratios (HRs) with their 
corresponding 95% CIs were reported. All variables were tested by the two-sided 
Wald x 
2
 test. 
Logistic regression 
Binary logistic regression was used to evaluate the influence of different individual 
factors on the risk of repetition. The unadjusted association between repetition and 
each factor was studied in univariable models. The adjusted association was studied 
with inclusion of factors that showed an association (p value <0.05) with repetition in 
multivariable models. Odds ratios (ORs) with their corresponding 95% CIs were 
reported. All variables were tested using the two sided Wald x² test. The Hosmer-
Lemenshow goodness-of-fit test was used to examine whether the multivariable 
models were adequate for the data, with a p-value larger than 0.5 indicating that the 
goodness-of-fit was accurate.
99
 
Classification trees
 
Classification trees were used to stratify the patients into groups according to the risk 
of repetition after DSH. The x 
2
 automatic interaction detection (CHAID) algorithm 
to build the tree was used. A CHAID analysis starts with all patients in one group. 
Each possible split on each factor is considered to find the split that leads to the 
strongest association with the dependent variable: repetition of self-harm after an 
index episode of self-harm (yes/no). The resulting groups were split until one of the 
following stop criteria were reached: tree depth was limited to three levels, no group 
with less than 50 patients was formed and no split with a Bonferroni adjustment of 
less than 0.05 was executed. 
Receiver operating curve 
To evaluate the performance of individual factors and different classification models 
and to discriminate between repeaters and non-repeaters, the area under the receiver 
operating curve (ROC: trapezoid rule) was calculated. An area under the curve 
(AUC) equal to 0.5 suggests no discrimination, 0.7 to <0.8 is acceptable, 0.8–0.9 is 
excellent and >0.9 is outstanding discrimination.
99
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Sensitivity and specificity 
To describe the decision rules´ ability to classify patients according to the risk of 
repetition correctly, the sensitivity (true repeater, i.e. the proportion of patients 
predicted to repeat according to the decision rules among those who did repeat) and 
specificity (true non-repeaters, i.e. the proportion of patients predicted not to repeat 
according to the decision rules among those who did not repeat) was calculated. In an 
ideal model, both sensitivity and specificity should be high. 
The Open Epi Program with the score method (corrected for continuity) was used to 
calculate the 95% confidence intervals (CI) for the sensitivity and specificity. This 
method is suitable for situations where the proportions are large, as is typically the 
case with measures of sensitivity and specificity.
100
 
 
Comparing groups 
To compare differences in baseline characteristics between the two hospitals and 
between early follow-up or no early follow-up, Fisher´s exact test and Pearson's chi-
squared (x 
2
) test was used with the statistical significance set at p<0.05. 
A summary of the different statistical methods chosen for the different studies is 
presented below in Table 3.  
Table 3 Statistical analyses used in the thesis 
 Study I Study II Study 
III 
Study 
IV 
Comparisons between two groups: 
Fischer's exact test 
Pearson's chi-squared (x 
2
) test 
   
 
X 
 
X 
Associations between variables and 
adjustment for confounders: 
Cox proportional hazard models 
Logistic regression 
 
 
X 
 
 
 
X 
  
 
 
X 
Stratification into groups according to 
different risks: 
Classification trees 
 
 
X 
 
 
X 
  
Evaluation of the predictive ability of 
individual factors and different  models: 
Receiver operating curve 
  
 
X 
 
 
X 
 
Description of different models ability of 
correct classification according to risk: 
Sensitivity and specificity 
  
 
X 
 
 
X 
 
 
The statistical analyses were performed using SPSS, versions 17, 18, 20. 
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ETHICAL CONSIDERATIONS 
All four studies were approved by the Regional Ethics Committee at Karolinska 
Institutet, Stockholm, Sweden. Reference numbers 2006/1049-31, 2011/238-31/1 and 
supplement 2011/1880 32. 
All studies were conducted in accordance with the Helsinki declaration. 
After receiving data from the registers of the Swedish National Board of Health and 
Welfare and Statistics Sweden there were no longer any personal identification 
number connected to any of the data used in the four studies but instead a serial 
number and the key to the number was kept by the Swedish National Board of Health 
and Welfare. This meant that all the data was anonymized and all analyses were 
performed in anonymized datasets. Risk of perception of breaches of privacy for 
individuals who unknowingly participates in a study is always present even though 
only including a systematization of previously collected information through hospital 
charts and registers. On the other hand, this type of studies give a  possibility to gain 
new and enhanced knowledge regarding this group of patients in order to be able to 
provide adequate care and offer a better treatment for future patients. 
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RESULTS 
STUDY I 
During the study period, 1679 patients were identified with an episode of DSH. 
Exclusion criteria were: death at the index episode (n=16), patient leaving the ED 
before a somatic or psychiatric assessment (n=8), hospital chart not available (n=41), 
incorrect classification in the register i.e. not a DSH according to the hospital chart 
(n=39), and a missing or inaccurate personal identification number (n=51). After 
exclusion criteria were met the study population consisted of 1524 patients. 
Risk factors found to be associated with repeated DSH included episode of DSH 
before index, female gender, self-injury as a method for DSH, self-injury requiring a 
surgical procedure, current psychiatric or antidepressant treatment and if the patient 
suffered from a substance use disorder or adult personality disorder or did not have 
children under the age of six.  
Within the first year after the index episode, 408 patients (26.8% [95% CI: 
24.6−29.0]) repeated DSH and 75% of these repeated DSH episodes occurred within 
six months and 10.5% within the first few days after the index episode (Figure 4).  
Figure 4 Time to repeated DSH within the first year after the index episode (n=408) 
 
In total 484 patients (31.8% [95% CI: 29.4–34.1]) repeated their DSH actions after 
the index episode within the whole time period (2003–2006). The follow-up period 
differed between the patients depending on the date of the index episode but all 
patients had a follow-up period of at least one year. Among the patients who repeated 
DSH, 26% attended another hospital than the one attended at the index episode. In 
total, the repeating DSH patients attended 31 different hospitals in Sweden during the 
time period. 
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Six per cent (96/1524) of the patients were deceased on 31 December 2006, including 
35 patients (2.3%) who had subsequently committed suicide. Among the patients who 
committed suicide, 63% were men and 46% were over the age of 45.   
The stratification according to the classification tree analysis showed that the 
occurrence of repeated DSH or suicide by patients attending the ED due to DSH 
ranged between 18% and 72% within different groups (Figure 5).  
The patients with the highest risk (47%–72%) of repetition had an episode of DSH 
before index and a current psychiatric contact. Alternatively, they had an episode of 
DSH before index without a psychiatric contact but a suicidal intention (48%). 
Another group with a high risk of repetition (47%) was patients without an episode of 
DSH before index with an adult personality disorder diagnosis and a psychiatric 
contact.  
In contrast, the group with the lowest occurrence of repetition, 18%, consisted of 
patients with no episode of DSH before index, no adult personality disorder 
diagnosis, and without antidepressant medication. 
 
Figure 5 Classification tree showing the factors which, at each step, had the 
strongest association with repeated DSH among patients attending the emergency 
department due to DSH (n = 1524) during the whole study period (2003-2006). The 
percentage of repeated DSH is based on the total number of patients in each node (n).  
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STUDY II 
The study population consisted of the same 1524 DSH patients described in Study I. 
To be able to compare the MSHR and also for a more clinical useful approach, 
repeated DSH or suicide within six months was chosen as outcome measure. The 
cumulative incidence for patients repeating their deliberate self-harm acts within six 
months was 20.3% (95% CI: 18.0–22.0). Of the 309 patients who repeated within six 
months, 3.8% (12/309) repeated by committing suicide. Among the 309 patients who 
repeated, 70% were women, the mean age was 39.5 years (18 to 91 years), and 26% 
were under 25 years of age.  
The unadjusted factors found in the Swedish material to be statistically significant    
(p < 0.05)  associated with repetition within six months using logistic regression were 
gender, parent with young children, unemployment, disability pension, current 
psychiatric treatment (subgroup admitted to psychiatric clinic), previous psychiatric 
treatment, episode of DSH before index, antidepressant treatment,  self-injury 
requiring a surgical procedure, and a precipitant event.  
In the adjusted model the following factors were statistically significant (p < 0.05): 
gender, parent with young children, current psychiatric treatment, previous 
psychiatric treatment, episode of DSH before index, antidepressant treatment, and 
self-injury requiring a surgical procedure. In addition marital status and housing 
status showed a statistically significant (p < 0.05) predictive ability when AUC was 
calculated for each individual factor. 
The classification tree analysis indicated that the four factors associated with 
repetition within six months were gender, antidepressant treatment, episode of DSH 
before index and current psychiatric treatment (subgroup admitted to psychiatric 
clinic).  
In order to evaluate the ability of different models to predict repetition within six 
months, ROC was used and AUC for the different models was compared: 
Use of all nine factors, in the adjusted model and when calculating AUC for each 
factor, found to be statistically significant (p < 0.05) associated with repetition within 
six months (Södersjukhuset Self-Harm Rule: SoS-9) yielded an AUC of 0.67, while 
use of the four factors (Södersjukhuset Self-Harm Rule: SoS-4) from the 
classification tree analysis yielded an AUC of 0.64.  
In comparison, the Manchester Self-Harm Rule yielded an AUC of 0.55 when applied 
to this material. When a low cut-off point (0.14 or lower) was chosen, the sensitivity 
for repetition was similar for all models while the Manchester Self-Harm Rule had a 
lower sensitivity and specificity when higher cut-off points were chosen. The models 
with nine and four factors were similar with respect to AUC and sensitivity and 
specificity (Figure 6). 
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The sensitivity and specificity for SoS-4 at different cut-offs when applied to the 
1524 DSH patients are shown in Table 4 and the sensitivity and specificity for MSHR 
in Table 5. 
 
Table 4 Södersjukhuset Self-Harm Rule (SoS-4)* as applied to 1524 DSH patients 
according to different cut-off points. 
Södersjukhuset 
Self-Harm Rule 
Cut-off point 0.14 Cut-off point 0.33 
                               Repeater  Nonrepeater  Total   Repeater Nonrepeater Total 
Moderate/high risk 279 993 1272  51      79   130 
Low risk  30 222   252 258 1136 1394 
Total cases 309 1215 1524 309 1215 1524 
Sensitivity 90%   17%   
Specificity 18%   93%   
Positive  
predictive values 
 
22% 
   
39% 
  
Negative predictive 
values 
 
88% 
   
81% 
  
Proportion  
repeater 
 
20% 
   
20% 
  
* The Södersjukhuset Self-Harm Rule includes the variables:  
gender, history of DSH, current psychiatric treatment (subgroup admitted to 
psychiatric clinic) and antidepressant treatment. Individuals with an estimated risk 
above the cut-off point are predicted to have a moderate/high risk of repetition. 
 
 
 
Table 5 Manchester Self-Harm Rule (MSHR)* as applied to 1524 DSH patients. 
Manchester  
Self-Harm Rule 
Repeater Nonrepeater Total 
Moderate/high risk 275 955 1230 
Low risk     34 260   294 
Total cases 309       1215 1524 
Sensitivity 89%   
Specificity 21%   
Positive predictive values 22%   
Negative predictive values 88%   
Proportion repeater 20%   
* The Manchester Self-Harm Rule includes the variables:  
history of self-harm, previous psychiatric treatment,  
self-poisoning with benzodiazepines and current psychiatric treatment.   
 
 
 25 
 
Figure 6 Evaluation of the ability to predict repeated deliberate self-harm (DSH) 
within six months in 1524 patients attending the emergency department due to DSH 
for different models. Results expressed by the ROC. 
 
 
STUDY III 
After exclusion criteria were met, i.e. not being > 18 years of age (n=2) and not 
having a valid personal identification number (n=1), the total study population 
consisted of 325 patients. Of these 325 patients, 222 were included at Södersjukhuset 
and 103 at Karolinska University Hospital Huddinge.  
Regarding baseline data there were two statistical significant differences between the 
two hospitals: first admission to a psychiatric clinic after DSH; 31.5% of the DSH 
patients at Södersjukhuset were admitted to a psychiatric clinic after DSH compared 
to 43.7% of the DSH patients at Karolinska University Hospital Huddinge and, 
second, self-injury, was more common at Karolinska University Hospital Huddinge 
(14.6%) than at Södersjukhuset (6.8%).  
The majority of the patients were admitted to a somatic clinic (72.1% of the patients 
at Södersjukhuset and 70.9% of those at Karolinska University Hospital Huddinge) 
but the length of stay in hospital was very short, the majority of the patients were only 
admitted for one day (200/233). The short length of stay (one day) was similar 
between the two hospitals. 
Cut-off point: 
0.33 
Cut-off point: 0.14 
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The cumulative incidence for patients repeating their deliberate self-harm acts within 
six months was 24.6% (95% CI: 19.9–29.3). Of the 80 patients who repeated within 
six months, 62.5% were women, the mean age was 28 years (18 to 94 years), and 
24% were under 25 years of age. Among the men, 30% repeated their DSH acts 
compared to 22% among the women. 
To evaluate the ability of the two models (SoS-4 and MSHR) to predict repetition the 
area under the ROC curve was used and AUC for the two models was compared. 
SoS-4 yielded an AUC of 0.60 (95% CI: 0.53−0.67). In comparison MSHR yielded 
an AUC of 0.56 (95% CI: 0.49−0.63). Both parameters are shown in Figure 7. 
The ROC shows possible combinations of sensitivity and specificity for the estimated 
risk of repeated DSH at different cut-off points for the different models (Figure 7). 
Application of the SoS-4 to this new prospective material yielded a sensitivity of 89% 
and a specificity of 12% when a cut-off point of 0.14 was chosen, while application 
of the MSHR yielded a sensitivity of 95% and a specificity of 18%. 
 
Figure 7 Evaluation of the ability to predict repeated DSH. Results expressed by 
ROC. 
 
 
 
Cut-off point 0.14 
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STUDY IV 
The study population consisted of 92 patients in the group with an early follow-up 
visit within 10 days and 233 patients in the group without an early follow-up visit 
within 10 days.  
At the six months follow-up 22 of 92 patients (24%) with an early follow-up had 
repeated their DSH acts compared to 58 of 233 patients (25%) without an early 
follow-up (Table 6).  
The unadjusted analysis showed no significant association between patients not 
receiving an early follow-up and repeated DSH within six months (OR 1.06 (95% CI: 
0.60−1.85)). There were unadjusted associations between episode of DSH before 
index, previous psychiatric contact, having a psychiatric diagnosis, admission to 
psychiatric clinic after DSH and repetition. After adjustment for all factors, the 
association between patients not receiving an early follow-up and repeated DSH 
within six months became slightly stronger but still not statistically significant (OR 
1.22 (95% CI: 0.62−2.38). After adjustment for factors that were statistically 
significant (either unadjusted or adjusted for all factors) the association between 
patients not receiving an early follow-up and repeated DSH was similar with OR 1.30 
and OR 1.15. 
Of the patients categorized as moderate/high risk patients according to SoS-4 31% 
(89/288) were seen at an early follow-up and of the patients categorized as low risk 
patients according to SoS-4 8% (3/37) were followed-up within 10 days. 
Of the patients categorized as moderate/high risk patients according to MSHR 30% 
(82/275) were followed-up within 10 days and of the patients categorised as low risk 
patients according to MSHR 20% (10/50) were followed-up within 10 days. 
In the group without an early follow-up 26 of the 233 patients (11%) were followed-
up after more than 10 days. Among all patients, the mean time from the index DSH 
episode to follow-up was 7.6 days (95% CI 5.8−9.4).  
 
Table 6 Follow-up within 10 days and repeated DSH within  
six months among 325 DSH patients in the ED. 
  
 Follow-up 
within 10 days 
No follow-up 
within 10 days 
 
Total 
 
Repeater 
 
22 (24%)  58 (25%) 80 
Nonrepeater 
 
      70 (76%) 175 (75%) 
 
245 
Total cases 92 (100%) 233 (100%) 325 
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DISCUSSION 
This thesis, focusing on deliberate self-harm patients in the somatic emergency 
department, showed that there are factors associated with a higher risk of repeated 
DSH and that these risk factors can be used to stratify patients into different groups 
regarding moderate/high or low risk of repeating. This thesis also showed that the 
clinical decision rules SoS-4 and MSHR can be of use, in a clinical ED setting, to 
correctly identify patients at higher risk of repeated DSH and that there was an 
indication that DSH patients seen at an early follow-up visit within 10 days by a 
psychiatric consultant were less prone to repeat their DSH acts. 
DELIBERATE SELF-HARM IN THE EMERGENCY DEPARTMENT  
The repetition rate of DSH among patients attending an ED due to DSH has been 
reported to be as high as 25% but most commonly reported is a repetition rate of 
about 15%. 
49 101
 The repetition rates in the studies were higher than commonly 
reported in previous studies which could be due to the national follow-up in which all 
new DSH episodes could be identified and not only repetition at the index episode 
hospital. Patients with history of DSH have a high risk of repeating their DSH acts 
and the study by Bergen et al showed an increasing risk with increasing DSH 
episodes.
102
 This might be another explanation to the higher repetition rate of DSH in 
Studies III and IV where a large number of the included patients had had episodes of 
DSH before the index episode. Patients who attend an ED due to DSH often repeated 
their DSH acts within a short period of time which also could be shown in Study I. In 
contrast to other studies, repeated DSH could be identified nationwide and it was 
demonstrated that the DSH patients (with an index episode at Södersjukhuset) had 
attended a large number of different hospitals with repeated episodes of DSH. 
A history of DSH is the most frequently reported and clinical relevant predictor of 
suicide. Among DSH patients the risk of suicide is up to 100 times higher than in the 
general population. It has been estimated that about 10-15% of DSH patients 
eventually die by suicide and studies have shown that the risk of subsequent suicide is 
highest within the first year after an episode of DSH.
103
 The study by Suominen et al., 
with a follow-up after DSH of 37 years, also showed that the risk remains high for a 
long period of time, even appearing to be an indicator of high risk for subsequent 
suicide throughout the whole adult lifetime.
104
 In Study I about two percent of the 
included DSH patients committed suicide during the follow-up period of between one 
and four years which is in line with reviews of follow-up studies of one to five years 
(0.5−3%).49 The finding of more men than women committing suicide and that the 
patients committing suicide were of older age is consistent from a global perspective.
2
 
Higher female to male ratio among DSH patients and higher male to female ratio 
among patients committing suicide, referred to as the gender paradox of suicidal 
behaviour, showed to be consistent in the studies as well. There was a tendency of 
higher rate of repetition among men than among women in Studies III and IV which 
is in accordance with recent statistics from the Swedish National Board of Health and 
Welfare showing an increase in young men admitted to hospital due to DSH.
14
 
Increase in admission to hospital due to DSH should be one alert of the importance 
and seriousness of DSH acts.  
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Risk factors shown in previous studies to be associated with repeated DSH, such as a 
history of DSH, female gender, psychiatric diagnoses of substance use disorder and 
adult personality disorder were also associated with repeated DSH in this Swedish 
population.
65
  
The association between self-injury requiring surgical procedure and repetition of 
DSH in Study I indicated a more severe DSH method and that the suicidal intention 
was high, which should alert clinical staff and other caretakers to make sure that this 
group of patients is provided with adequate resources, especially since previous 
studies have shown evidence of a strong association between severe DSH methods, 
higher suicide intent and subsequent suicide.
105-107
  
The association between current antidepressant treatment and repeated DSH could 
indicate that these patients were at higher risk of repeating due to having a psychiatric 
disorder severe enough to be treated. It has been shown that the risk of suicidal 
behaviour among depressed patients treated with antidepressants is present during the 
first two weeks of treatment. If these patients had recently started their antidepressant 
treatment this might explain the association with repeated DSH as the patients often 
repeated within a short period of time.
79
 
When patients with young children attend an ED due to DSH other authorities are, 
owing to Swedish law, involved and other caretakers are quickly alerted, which is not 
the case with patients without young children and might explain the protective factor 
shown in our studies of having young children regarding risk of repeated DSH. 
The risk stratification analysis indicated that within the group attending an ED due to 
DSH, there were patients with different risks of repetition and the stratification 
implied that in order to identify patients with high risk of DSH repetition, clinical 
staff should take special note of patients with a previous DSH episode who have a 
psychiatric contact or those without a psychiatric contact but with suicidal intention. 
Furthermore, among patients without a previous DSH episode, those with an adult 
personality disorder diagnosis and a psychiatric contact are at high risk of repeating. 
PREDICTING REPEATED DELIBERATE SELF-HARM 
Identifying patients at risk of subsequent suicidal behavior is of great importance to 
be able to provide adequate care to these patients. Due to the complex and 
multifactorial causes of suicidal behaviour, including both exposure to environmental 
stress and genetic and biological contribution, the prediction of repeated DSH is not 
an easy task. Also methodological difficulties contribute to the difficulty of predicting 
repeated DSH such as for example some factors being strongly associated with 
repeated DSH but not showing predictive capabilities due to low prevalence. 
The Manchester Self-Harm Rule (MSHR) is a clinical decision rule developed and 
first validated in a UK population by Cooper et al.
62 108
 The MSHR uses four clinical 
correlates: history of self-harm, previous psychiatric treatment, benzodiazepine used 
as self-poisoning drug and current psychiatric treatment to predict repeated DSH 
within six months among patients attending an ED due to DSH. In Study II the 
MSHR was validated in a new setting and in a new population and correctly 
identified patients at higher risk of repeated DSH. 
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The clinical decision rule, Södersjukhuset Self-Harm Rule (SoS-4), was developed in 
Study II according to risk factors associated with repeated DSH within six months in 
a Swedish population. The clinical decision rule was developed to facilitate 
assessment in somatic EDs with or without psychiatric expertise. The SoS-4 uses 5 
clinical correlates: gender, history of DSH, current psychiatric treatment, admitted to 
psychiatric clinic and antidepressant treatment to predict repeated DSH within six 
months among patients attending an ED due to DSH. 
Compared to many other studies regarding factors associated with DSH and 
repetition, the analysis was taken one step further and evaluated the predictive 
capabilities of the factors associated with repetition.
109 110
 Although a factor is highly 
associated with repetition (has an OR significantly above or below 1), this is not 
equivalent to being a strong predictor of repetition. For example, although patients 
with a self-injury requiring a surgical procedure had five times higher odds of 
repeating DSH (Study II), this factor was not useful in predicting because the absolute 
number of patients in this group was small. 
The prospective multicenter Study III showed that both the SoS-4 and the MSHR 
correctly identify patients with a higher risk of repeating their DSH acts within six 
months. The MSHR is easy to implement as all patients with any of the four clinical 
characteristics are defined as moderate/high risk patients. In comparison, the SoS-4 
gives a more detailed estimated probability of repetition but require a calculation 
which can be easily carried out using a preprogrammed calculation sheet. 
 
It is not without controversy to use clinical decision rules to identify patients at high 
risk of repetition and, for example, in the UK, the National Institute for Health and 
Clinical Excellence (NICE) guidelines do not recommend the use of risk assessment 
tools and scales to predict future suicide or repetition of self-harm.
111
 Of course, the 
ideal would be to offer all DSH patients a psychological intervention that is 
specifically structured for people who self-harm, with the aim of reducing self-harm, 
but if that is not possible, due to a lack of availability or for other reasons, decision 
rules might be used as a preliminary guide for ED physicians to identify patients who 
are at higher risk of repetition and help prioritize for more urgent psychological 
intervention for these patients. Also the study by Cooper et al. showed that the 
clinical decision rule, MSHR, performed better than the global clinical assessment of 
ED clinicians and mental health specialists which would suggest improved accuracy 
of risk assessment when adding the use of a clinical decision rule.
108
 
REDUCING REPEATED DELIBERATE SELF-HARM 
The high risk of subsequent suicide after DSH and also the high risk of repeating 
DSH indicate that patients treated due to DSH and especially those with 
characteristics indicating a higher risk should be targeted in prevention programs.
112
 
Indicated preventive measures by simple contact-type interventions such as mailed 
postcards to DSH patients after discharge have in some studies been shown to 
influence the repetition rates of DSH.
113-115
 Also some studies investigating improved 
access to health care services, such as provision of emergency or crisis cards, have 
shown a decrease in repetition rates of DSH.
116 117
 There has though been proposed a 
need for further investigation of simple contact-type interventions to be able to show 
their effectiveness of reducing repeated DSH due to inconsistency of results .
118
  
 31 
 
In Study IV it was investigated if an early follow-up (sort of simple contact-type 
intervention) could reduce the high repetition rate of DSH and it gave a slight 
indication of early followed-up patients being less inclined to repeat their DSH acts, 
although not with statistical significance. Previously known risk factors for repeated 
DSH were significantly associated with repetition within six months in this study as 
well and influenced the impact of the association between an early follow-up and 
repeated DSH. 
61 68
 
It is of importance to provide adequate follow-up care to all DSH patients and 
especially those at high risk of repetition. Only 30% of patients at moderate/high risk 
of repeating their DSH acts, according to the clinical decision rules used in Study IV, 
received an early follow-up hence the majority of DSH patients with a higher risk of 
repeating their DSH actions did not receive an early follow-up at a psychiatric care 
unit. In all only about one fourth of the patients attending the ED due to DSH were 
seen at an early follow-up after the DSH episode. Previous studies have also shown 
that many DSH patients do not receive follow-up after a DSH episode. 
119 120
  
Other studies have indicated the influence of problem solving therapy approaches and 
simple contact-type interventions on reducing repetition rates. 
90 121
 It is also of 
importance to implement universal and selected preventive measures to prevent 
individuals from engaging in DSH since the repetition of DSH and also subsequent 
suicide is hard to fully prevent regardless of the strategies used.  
Patients who deliberately harm themselves often report negative responses from staff 
in health services and especially in emergency departments which may be due to 
professionals´ lack of understanding of DSH and may also be due to the lack of 
evidence base for treatments. Patients who deliberately harm themselves deserve the 
same standard care as those with other medical conditions such as myocardial 
infarction or acute asthma. Understanding and finding best ways of treating DSH 
patients is an essential part of effective suicide prevention. 
LIMITATIONS  
One limitation of the studies was that if data on the decision rule sheet or on the study 
protocol were missing it was not possible to investigating this further and in the 
statistical analysis missing data were classified as no. This would imply that the 
estimated risks might be underestimated. 
One limitation of Studies I and II was that the patients were not prospectively 
assessed according to a study protocol. All information was obtained retrospectively 
from somatic and psychiatric hospital records. Some doctors wrote elaborate records 
while others were rather brief. To minimize the impact of heterogeneous information 
a strict protocol was used when extracting data from the medical and psychiatric 
records in order to achieve high data reliability. Omission of information played a 
more important role than incorrect information. If, for example, a psychiatric record 
stated that a patient had been sexually abused, he or she probably had been abused. If 
nothing about sexual abuse was found in the psychiatric records, the patient still 
might have been abused. There could have been an underestimation of the occurrence 
of risk factors based on information extracted from the medical and psychiatric 
records.  
 32 
One limitation of Studies III and IV was the different strategies for identification of 
DSH patients at the two hospitals in cases where the ED physician who treated the 
patient had not filled in the form. To ensure inclusion of all DSH patients at the 
Karolinska University Hospital all referrals from the somatic clinic to the psychiatric 
clinic were examined and at Södersjukhuset all emergency records were examined 
which might have influenced the identification of DSH patients at the two different 
hospitals.  
When developing the clinical decision rule SoS-4 some factors were strongly 
associated with repeated DSH such as for example self-injury requiring a surgical 
procedure but did not show good predictive ability due to the small number of 
patients in this group. The individual risk of the patients with self-injuries requiring a 
surgical procedure is of course high but not useful to predict repetition among a large 
group of DSH patients.  
IMPLICATIONS FOR FUTURE RESEARCH 
DSH is poorly understood in society and even among those who in their working 
lives encounter people who harm themselves such as nurses and doctors.
122
 People 
who harm themselves are subject to stigma and hostility. A positive effect of contact 
based interventions on staff attitudes and DSH patients, as well as reduced repetition 
rate, has been demonstrated.
123 124
 Further studies should include an evaluation of 
changes in staff attitudes towards DSH patients and DSH patient’s opinions regarding 
follow-up care in addition to the outcome of repeated DSH. 
Due to DSH patients often repeating their DSH acts within a short period of time, 
further studies on early intervention and its effect on repeated DSH is necessary in 
order to find ways of reducing the high repetition rates. 
The clinical decision rule SoS-4 has not yet been evaluated in another setting than 
large university hospitals in Stockholm, Sweden. Further prospective studies are 
therefore needed to validate the rule in new settings and other populations. 
There is evidence supporting the role of behavioural therapy in preventing suicidal 
behaviour in specific subgroups although its effect in a heterogeneous DSH 
population remains to be investigated. It is also of importance to implement and 
evaluate universal and selected prevention strategies to prevent individuals from 
engaging in DSH at all as the repetition of DSH as well as subsequent suicide is hard 
to fully prevent regardless of the strategies used. 
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CONCLUSION 
 
Patients who harm themselves are often seen in somatic emergency departments and 
it is important for all healthcare personnel, and especially for ED physicians, to better 
understand how these patients should be assessed and treated.  
 
 The risk of repetition is high among some DSH patients while it is lower 
among others in the heterogeneous group of patients seeking acute somatic 
care due to DSH. There are risk factors associated with repeated DSH, which 
means that DSH patients can be stratified according to different risks of 
repetition. 
 
 The clinical decision rules, SoS-4 and MSHR, can identify, with high 
sensitivity, patients who will repeat their deliberate self-harm acts. 
Application of either of these rules can facilitate assessment in the ED and 
help focus right resources on patients at higher risk. All in all, it is difficult to 
predict repetition among DSH patients but previous deliberate self-harm and 
current psychiatric treatment are two important predictors. 
 
 The group of DSH patients is heterogeneous and adequate strategies for 
reducing the high risk of repeated DSH are not easily applicable to different 
populations. There is an indication of early followed-up patients being less 
inclined to repeat their DSH acts after adjusting for well known risk factors 
associated with repeated DSH. 
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SAMMANFATTNING 
 
Vi som arbetar på de somatiska sjukhusens akutmottagningar slås ofta av det stora 
antalet patienter som behöver vård till följd av avsiktliga självdestruktiva handlingar 
(självskador) och av att många av dessa patienter återkommer vid upprepade tillfällen 
tillföljd av nya självskador. Viljan att leva är grundläggande för alla människor och 
att någon skadar sig själv måste tas på allvar och vara en varning att en individ inte 
klarar av en viss situation eller period i livet.  
Omkring tio miljoner människors skadar sig själva och en miljon människor begår 
självmord varje år över hela världen. Självskador är en betydande orsak till enskilda 
lidanden och är även en belastning för hälso-och sjukvården. Att ha skadat sig själv är 
den starkaste riskfaktorn för självmord, patienter som skadat sig själva har upp mot 
hundra gånger så hög risk att ta livet av sig jämfört med individer som inte har skadat 
sig själva. Mellan 15−25 % av patienterna som kommer till en akutmottagning på 
grund av en självskada, skadar sig själva igen och risken för en ny självskada är högst 
inom det första halvåret till året efter en självskada.  
Syftet med denna avhandling var att studera vilka riskfaktorer det finns som kan 
kopplas till att återkomma med ny självskada, att utveckla och pröva ett verktyg för 
att kunna hitta patienter med högre risk för att återkomma med ny självskada och att 
undersöka om en tidig uppföljning med ett återbesök inom 10 dagar skulle kunna 
minska den höga andel patienter som återkommer med nya självskador.  
Studie I: Under tre år sökte 1524 patienter Södersjukhusets akutmottagning tillföljd 
av självskada och kunde inkluderas i studien. Tidigare och nya självskador hos dessa 
patienter kunde upptäckas genom tillgång till nationella register. De riskfaktorer som 
kunde kopplas till att återkomma med ny självskada var följande: att ha skadat sig 
själv tidigare, kvinnligt kön, att skära sig och att skära sig så allvarligt att det krävdes 
en kirurgisk operation, att ha en pågående psykiatrisk eller antidepressiv behandling, 
att ha en beroendediagnos eller en personlighetsstörnings diagnos och att inte vara 
förälder till små barn. Patienterna kunde grupperas efter deras risk för ny självskada 
och det fanns grupper med låg risk (18 %) för ny självskada och hög risk (47-72%) 
för ny självskada.  
Studie II: De riskfaktorer som var kopplade till att återkomma med ny självskada i 
Studie I användes i denna studie för att ta fram ett verktyg för att kunna identifiera 
patienter med högre risk att återkomma med ny självskada, Södersjukhuset Self-Harm 
Rule (SoS-4). Ett verktyg, från England, som också tagits fram för bedömning av 
risken för att återkomma med ny självskada, Manchester Self-Harm Rule (MSHR) 
utvärderades också i denna studie. När MSHR utvärderades på de 1524 patienterna i 
Studie I visade det en sensitivitet på 89 % och en specificitet på 21 %. Det nya 
verktyget, SoS-4, visade en sensitivitet på 90 % och en specificitet på 18 %. 
Studie III: För att kunna utvärdera SoS-4 och MSHR förmågor att hitta patienter med 
högre risk att återkomma med ny självskada undersöktes 325 nya patienter som sökt 
Södersjukhusets och Karolinska Universitetssjukhuset Huddinges akutmottagningar 
tillföljd av självskada. Patienterna följdes under sex månader och genom tillgång till 
nationella register kunde nya självskador upptäckas. När SoS-4 utvärderades på denna 
nya grupp av patienter visade det en sensitivitet på 89 % och en specificitet på 12 % 
och motsvarande visade MSHR en sensitivitet på 95 % och en specificitet på 18 %. 
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Studie IV: Uppföljning av självskadepatienter och dess inverkan på att återkomma 
med ny självskada studerades i samma population som Studie III. Återbesök till en 
psykiatrisk klinik inom 10 dagar registrerades som ett tidigt återbesök. När hänsyn togs 
till kända riskfaktorer för att återkomma med ny självskada så uppvisade patienterna 
som erhöll ett tidigt återbesök en viss benägenhet att återkomma i mindre utsträckning. 
Studien visade också att en stor andel av patienter som skadar sig själva inte följs upp 
överhuvudtaget, inte ens de patienterna med högre risk att återkomma med ny 
självskada. 
Slutsatser: Denna avhandling visade att det finns riskfaktorer som är kopplade till att 
återkomma med ny självskada och att dessa riskfaktorer kan användas för att hitta 
patienter med högre risk för att återkomma med nya självskador. Risken för att 
återkomma med ny självskada är högre hos vissa patienter och lägre hos andra. De båda 
kliniska verktygen MSHR och SoS-4 kan vara användbara, tillsammans med en klinisk 
bedömning av självskadepatienter, för att hitta patienter med högre risk att återkomma 
med ny självskada. Båda verktygen fokuserar på hög sensitivitet då det är av större vikt 
att hitta patienter med högre risk att återkomma än att korrekt avfärda de med lägre 
risk. Det är svårt att förutse vilka patienter som kommer att återkomma med ny 
självskada men att ha skadat sig själv tidigare och att ha en pågående psykiatrisk 
kontakt är två viktiga indikatorer på att risken är högre. Gruppen av patienter som 
skadar sig själva är heterogen och adekvat uppföljning är inte lätt att applicera på olika 
populationer. Det fanns en benägenhet hos patienter som erhållit ett tidigt återbesök att 
i mindre utsträckning återkomma med ny självskada när hänsyn togs till tidigare kända 
riskfaktorer kopplade till att återkomma med ny självskada.  
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